ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading 

Please follow and like us:
fb-share-icon
Tweet
Pin Share

Related posts:

Default ThumbnailACTION FOR DAY Global cues-US: Industrial production Ex-date for HCC rights issue Ex-date for Gujarat Ambuja Exports 1:1 bonus issue Waaree Renewable Technologies stock split from 10 to 2 Lock-in period ends for-Ratnaveer Precision (45%)+EMS Ltd (53%) SIP your way to smiles Diversify today to be happier tomorrow!Diversify today to be happier tomorrow!SIP your way to smiles Diversify today to be happier tomorrow!Diversify today to be happier tomorrow! HDFC bank in Focus Finally HDFC bank completes stake sale in HDFC Credila for Rs 9553 cr Expect this amount to be included in this quarter’s resultsHDFC bank in Focus Finally HDFC bank completes stake sale in HDFC Credila for Rs 9553 cr Expect this amount to be included in this quarter’s results Default ThumbnailUS DATA US – GDP (2Q 2024Y) = +3% QoQ (Expect +2.3%) Initial Jobless Claims = 218k (Expectation 224k) Durable Goods Orders (Aug) = 0% mom (Expectation -2.8%) US DATA US – GDP (2Q 2024Y) = +3% QoQ (Expect +2.3%) Initial Jobless Claims = 218k (Expectation 224k) Durable Goods Orders (Aug) = 0% mom (Expectation -2.8%)
Latest
market